DB Asset Management launches active ETF focused on new drug developers
AI Summary- DB Asset Management listed the DB Mighty New Drug Focus Bio Active ETF on the Korea Exchange.
- The fund uses FIC and BIC standards to select innovative drug-development companies.
- DB Asset Management previously launched its Mighty Biosimilar & CDMO Active ETF in late 2024.